-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $620

Benzinga·07/27/2026 18:08:52
Listen to the news
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $640 to $620.